Halozyme Therapeutics (HALO) Ownership

HALO$100.27-0.40 -0.40%
BiotechnologyLarge CapValue StockGrowth StockHigh Quality
Compare
Market cap$11.43BEnterprise value$16.78BRevenue (TTM)$1.66BMarket positionTop 25%

Score

69
Bullish
Value
61
Quality
85
Growth
62

Ownership data loads after the page opens.

Halozyme Therapeutics (HALO) Ownership

HALO price $100.27 -0.40 -0.40%

Ticker
HALO
Price
$100.27
Change
-0.40 -0.40%
Market cap
$11.43B
P/E
27.64
Forward P/E
9.97
Dividend yield
0.00%
Beta
0.90
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
61
Quality
85
Growth
62

Stocklytics score rationale: value 61, quality 85, growth 62.

AI Score 70. Halozyme Therapeutics, Inc. has a strong gross profit margin of approximately 82.4% and a healthy current ratio of 2.7, indicating solid financial health

Insights · Forecast · Financials · Learn

Stocklytics home · Screener